Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04760301 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Local Tranexamic Acid During Vaginal Hysteractomy to Reduce Blood Loss

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 6, 2025 (before its estimated July 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Jan 2022 to Jul 2025v3 Show 6 more changesShow less
    • Enrollment target: 70 to 60
    • Study completion date: Jan 2022 to Jun 2026
    • Interventions: IV 1 g normal saline (Other), IV 1 g tranexamic acid (Drug), local normal saline injection to cervix (Other), local tranexamic acid… to local normal saline injection to cervix (Other), local tranexamic acid injection (Drug)
    • Site details revised at 1 of 2 sites
    • Study arms: 4 to 2
    • Study description expanded, about 2 words
  2. Primary endpoint revised
    • Study sites: 1 to 2
    • Study description expanded, about 48 words
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Assessing the efficiency of Prophylactic use of local tranexamic acid during vaginal hysterectomy to reduce blood loss during operation
Trial Details
NCT Number NCT04760301
Lead Sponsor Meir Medical Center
Conditions
(from sponsor)		 Blood Loss
Related terms Hemorrhage
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov